Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study
This completed population-based study investigates whether fingolimod use in people with multiple sclerosis is associated with skin cancer r…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma [NA]
This clinical trial update reports the completion of NCT04920162, a study investigating new predictive markers of the immune response in mel…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Skin Health Online for Melanoma: Better Risk Assessment [NA]
A completed clinical trial evaluating Skin Health Online for Melanoma to improve risk assessment; results are posted.
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of Pegilodecakin (LY3500518) in patients with advanced solid tumors has completed, spanning multiple indications including mel…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 [Phase 1, Phase 2]
Phase 1a/Phase 2 study evaluating safety, preliminary efficacy, PK and PD of ST-067 in various cancers; currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management
A clinical trial investigates whether physical activity influences immunotherapy-related toxicities in melanoma patients. The study is curre…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma [Phase 1, Phase 2]
The document reports ongoing recruitment for a phase 1/phase 2 trial evaluating intradermal ipilimumab plus nivolumab in high-risk stage II …
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Compassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical Resection
The compassionate use program for BRAF mutation-positive melanoma patients after surgical resection is no longer available.
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY) [Phase 1, Phase 2]
Phase I/IIa dose-finding study evaluating a triplet regimen of relatlimab, ipilimumab, and nivolumab as first-line therapy for metastatic me…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology
This clinical trial update describes the 4D PICTURE Project evaluating Metro Mapping to support shared decision making in oncology, sponsore…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Imaging FDG Flare in Melanoma
The update summarizes results from a completed study investigating FDG PET imaging flare in metastatic melanoma, with results posted in 2024…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults
A recruiting clinical study from University Hospital Tuebingen investigating risk factors, exposomics, and genetic susceptibility for melano…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery [NA]
A clinical trial evaluating nicotine replacement therapy, motivational interviewing, cognitive behavioral therapy, and hypnotherapy for smok…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination [Phase 1]
Pfizer's Phase 1 study of PF-07329640, given alone or in combination, in advanced/metastatic solid tumors including non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) [Phase 1]
HAMMER I is a Phase I trial evaluating hepatic ablation of melanoma liver metastases to enhance response to immunotherapy; the study status …
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours [Phase 1]
This clinical trial update reports the completion of a first-in-human Phase 1 study evaluating AZD8701 with or without durvalumab in adults …
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types [Phase 1]
A Phase 1 study evaluating MT-8421 as monotherapy and in combination with nivolumab in selected advanced solid tumors has been terminated. T…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer [Phase 2]
A Phase 2 clinical trial update on Cardonilmab for second-line or higher advanced melanoma and advanced renal cancer, focusing on safety and…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated with Dabrafenib/ Trametinib +/- Immunotherapy [Phase 2]
Phase 2 trial update on managing pyrexia with an IL-6 antibody in BRAF-positive melanoma patients treated with dabrafenib/trametinib; the tr…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 trial update evaluating SB 11285 alone and in combination with atezolizumab in patients with advanced solid tumors, includ…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma [Phase 1]
Phase 1 trial evaluating a personalized neoantigen vaccine in combination with locally administered ipilimumab and systemic nivolumab for ad…
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: DermaSensor Postmarket Surveillance Study [NA]
DermaSensor, Inc. is conducting a postmarket surveillance clinical trial to monitor device performance in melanoma/skin conditions; the stud…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Fecal Microbiota Transplant (FMT) in Melanoma Patients [Phase 2]
A Phase 2 trial evaluating fecal microbiota transplant in melanoma has completed, with results posted on 2024-10-30.
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma [Phase 2]
Phase 2 trial evaluating dabrafenib, trametinib, and spartalizumab in BRAF V600E/V600K mutation-positive stage IIIB/IIIC/IIID cutaneous mela…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy [NA]
The Netherlands Cancer Institute reports ongoing recruitment for a trial validating ICG-99mTc-nanoscan as a hybrid tracer for sentinel lymph…